Byrne Asset Management LLC Bristol Myers Squibb CO Transaction History
Byrne Asset Management LLC
- $147 Million
- Q4 2025
A detailed history of Byrne Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Byrne Asset Management LLC holds 2,279 shares of BMY stock, worth $106,679. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,279
Previous 1,798
26.75%
Holding current value
$106,679
Previous $81,000
30.86%
% of portfolio
0.07%
Previous 0.06%
Shares
17 transactions
Others Institutions Holding BMY
# of Institutions
2,732Shares Held
1.58BCall Options Held
28.7MPut Options Held
28.6M-
Vanguard Group Inc Valley Forge, PA199MShares$9.3 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...